117 related articles for article (PubMed ID: 1858528)
1. Modulation by interferon alpha of the decreased natural killer activity in patients with glioblastoma.
Lapeña P; Isasi C; Vaquero J; Martinez R; Alvarez-Mon M
Acta Neurochir (Wien); 1991; 109(3-4):109-13. PubMed ID: 1858528
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and alpha-interferon.
Akbar AN; Fitzgerald-Bocarsly PA; Giardina PJ; Hilgartner MW; Grady RW
Clin Exp Immunol; 1987 Nov; 70(2):345-53. PubMed ID: 3427826
[TBL] [Abstract][Full Text] [Related]
3. Natural killer and natural killer-like cell activity of peripheral blood and intrathyroidal mononuclear cells from patients with Graves' disease.
Tezuka H; Eguchi K; Fukuda T; Otsubo T; Kawabe Y; Ueki Y; Matsunaga M; Shimomura C; Nakao H; Ishikawa N
J Clin Endocrinol Metab; 1988 Apr; 66(4):702-7. PubMed ID: 3257969
[TBL] [Abstract][Full Text] [Related]
4. Synergism between alpha-interferon and interleukin-2-activated killer cells: in vitro studies.
Di Raimondo F; LaPushin R; Hersh EM
Acta Haematol; 1987; 78 Suppl 1():77-83. PubMed ID: 3124452
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cells and interferon responses in patients with systemic lupus erythematosus.
Tsokos GC; Rook AH; Djeu JY; Balow JE
Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954
[TBL] [Abstract][Full Text] [Related]
6. Concomitant effect of 2'-deoxycoformycin on natural killer cell activity and tumour cell sensitivity to lysis in hairy cell leukaemia--discordant effects of alpha interferon.
Lahat N; Aghai E; Merchav S; Kinarty A; Sobel E; Froom P
Scand J Immunol; 1990 Aug; 32(2):205-9. PubMed ID: 2389114
[TBL] [Abstract][Full Text] [Related]
7. The effect of recombinant alpha 2-interferon on defective natural killer cell activity in multiple sclerosis.
Hirsch RL; Johnson KP
Neurology; 1985 Apr; 35(4):597-600. PubMed ID: 3982654
[TBL] [Abstract][Full Text] [Related]
8. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
[TBL] [Abstract][Full Text] [Related]
9. Effects of micro environmental factors on natural killer activity (NK) of beta thalassemia major patients.
Atasever Arslan B; Erdem-Kuruca S; Karakas Z; Erman B; Ergen A
Cell Immunol; 2013 Apr; 282(2):93-9. PubMed ID: 23770717
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of an acyltripeptide, FK565, on NK-cell activity, LAK-cell generation and cytokine production by human mononuclear cells.
Wang YL; Whiteside TL; Friberg D; Herberman RB
Immunopharmacology; 1989; 17(3):175-85. PubMed ID: 2504680
[TBL] [Abstract][Full Text] [Related]
11. Modulation of natural killer activity by aspirin: I. In vitro effect of aspirin.
Porzsolt F; Wolf W
J Interferon Res; 1983; 3(1):11-7. PubMed ID: 6842038
[TBL] [Abstract][Full Text] [Related]
12. Long-term killing of natural killer-resistant target cells by interferon-alpha-, interferon-gamma-, and interleukin-2-activated natural killer cells.
Sarzotti M; Klimpel GR; Baron S
Nat Immun Cell Growth Regul; 1989; 8(2):66-75. PubMed ID: 2503715
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 2- and interferon alpha induced natural killer cell activity as a marker of progression in hairy cell leukemia.
Bigda J; Mysliwska J; Baran W; Hellmann A; Mysliwski A
Leuk Lymphoma; 1993 Mar; 9(4-5):371-6. PubMed ID: 8348073
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2 induces cytotoxic activity in lymphocytes from regional axillary nodes of breast cancer patients.
Bonilla F; Alvarez-Mon M; Merino F; de la Hera A; Alés JE; España P; Durántez A
Cancer; 1988 Feb; 61(4):629-34. PubMed ID: 3257405
[TBL] [Abstract][Full Text] [Related]
15. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
[TBL] [Abstract][Full Text] [Related]
16. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
17. Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells.
Jewell AP; Worman CP; Giles FJ; Goldstone AH; Lydyard PM
Leuk Lymphoma; 1992 Aug; 7(5-6):473-80. PubMed ID: 1362916
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell activity in tumor-draining lymph nodes: investigations in patients with malignant melanoma and head and neck cancer.
Micksche M; Vinzenz K; Kokoschka EM; Kokoschka R
Nat Immun Cell Growth Regul; 1985; 4(6):315-27. PubMed ID: 4088287
[TBL] [Abstract][Full Text] [Related]
19. Interferon-alpha-2b enhances the natural killer activity of patients with transitional cell carcinoma of the bladder.
Carballido JA; Moltó LM; Manzano L; Olivier C; Salmerón OJ; Alvarez de Mon M
Cancer; 1993 Sep; 72(5):1743-8. PubMed ID: 8348503
[TBL] [Abstract][Full Text] [Related]
20. Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells.
Riccardi C; Giampietri A; Migliorati G; Cannarile L; D'Adamio L; Herberman RB
Int J Cancer; 1986 Oct; 38(4):553-62. PubMed ID: 2944847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
